Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma entities : Zealand pharma a::S save search
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma management for
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Total number of shares and voting rights in Zealand Pharma at March 31, 2024
Published: 2024-03-31 (Crawled : 16:20) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma total
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma employee
Zealand Pharma major shareholder announcement: Van Herk Investments
Published: 2024-03-21 (Crawled : 17:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma investments
Zealand Pharma major shareholder announcement: Polar Capital
Published: 2024-03-19 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-19 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
New Employee Elected Directors to the Board of Zealand Pharma A/S
Published: 2024-03-13 (Crawled : 21:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma employee
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-08 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma employee
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
Published: 2024-03-01 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma conference health care
Zealand Pharma convenes its Annual General Meeting 2024
Published: 2024-02-27 (Crawled : 07:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma meeting
Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
pharma year financial results
Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Published: 2024-02-26 (Crawled : 07:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma liver disease fibrosis trial results
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
Published: 2024-02-20 (Crawled : 07:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma conference year financial results
Total number of shares and voting rights in Zealand Pharma at January 31, 2024
Published: 2024-01-31 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma total
Zealand Pharma major shareholder announcement: Van Herk Investments
Published: 2024-01-26 (Crawled : 17:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma investments
Zealand Pharma major shareholder announcement: J O Hambro Capital Management
Published: 2024-01-19 (Crawled : 17:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma management
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.